Merck MRK announced that the FDA has accepted for review the new drug application (“NDA”) seeking approval for its investigational, once-daily, oral, two-drug, single-tablet regimen of ...

Rhythm Pharmaceuticals' experimental drug helped patients with a rare form of obesity caused by brain damage cut weight in a small study, the drugmaker said on Monday, sending its shares 24% higher in ...

The most read stories this past month detailed the passing of Dimitrios Karmpaliotis and news on Evoque and COVID-19.

The Pathophysiological and Pharmacological Basis of Current Drug Treatment of Migraine Headache Doodipala Samba Reddy Disclosures Expert Rev Clin Pharmacol. 2013;6 (3):271-288.

Each tablet contains 119 mg sumatriptan succinate and 500 mg naproxen sodium. Such a combination is suggested to produce faster and better control of acute migraine.